These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 26965352)
21. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Lotufo-Neto F; Trivedi M; Thase ME Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483 [TBL] [Abstract][Full Text] [Related]
22. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. Kahn D; Silver JM; Opler LA J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181 [TBL] [Abstract][Full Text] [Related]
23. The clinical relevance of treatment with antidepressants. Nolen WA Acta Neuropsychiatr; 1995 Jun; 7(2):52-4. PubMed ID: 26965352 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
25. Managing antidepression overdoses. Miller J Emerg Med Serv; 2004 Oct; 33(10):113-9. PubMed ID: 15553532 [TBL] [Abstract][Full Text] [Related]
26. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. Ponto LB; Perry PJ; Liskow BI; Seaba HH Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909 [TBL] [Abstract][Full Text] [Related]